Recommended Tools
AbSeek™ encompasses antibody sequence analysis, structure and function prediction, lead optimization, de novo generation, and visualization, among others, covering all stages of antibody discovery and engineering from screening to optimization for efficient innovation.
Free Tools Limited Time
Sequence Analysis
Function Prediction
Lead Optimization
Structure Prediction
New
Molecule Generation

Features & Advantages
Integration
Combines multiple algorithms to provide a one-stop service that meets all needs in antibody discovery and engineering.
Expertise
Tailors UI and data visualization methods based on the characteristics of antibody data for better suitability.
Advancement
Continuously updates cutting-edge AI algorithms to ensure the platform's timeliness and advancement.
Data Security
Committed to providing users with a secure and reliable data environment, alleviating concerns about data leakage.
News
Cyagen Talk|AI-Powered Antibody Discovery: From HUGO-Ab Mice to Predictive Models
AbSeek™: Intelligent Antibody Computational Platform
2025-03-19
More >>【Frontier Express】Antibodies | Targeted Therapy for Antihistamine-Refractory Chronic Spontaneous Urticaria: An Evidence-Graded Approach to Agent Selection
2026-09-28
【Frontier Express】Science translational medicine | Engineered Probiotics Mediate Tumor-Targeted Enzyme/Prodrug Chemotherapy and Immunotherapy Combination Strategy
2026-09-28
【Frontier Express】Advanced Science | Brain-Penetrant Nanobody Reveals GSK3β-Driven Proline-Directed Phosphorylation as a Master Regulator of Ischemic Neurodegeneration
2026-09-28
【Frontier Express】Antibodies | A Nationwide Cohort Study of Systemic Sclerosis-Related Autoantibodies and Analysis of Their Clinical Phenotype Associations
2026-09-27
【Frontier Express】Nature Cancer | Fc-Optimized GITR Antibody Promotes Antitumor Immunity by Enhancing CD4+ T Cell–Dendritic Cell Crosstalk
2026-09-26
【Frontier Express】Nature Medicine | Interpretation of the Phase 1b Clinical Trial of Short-Half-Life Anti-PD-L1 Antibody IBC-Ab002 in Alzheimer's Disease
2026-09-24
【Frontier Express】Bioactive Materials | Nanoadjuvant-Mediated Membrane Poration Delivers cGAMP and Halicin to Regulate Mitochondrial Metabolism, Inhibit PD-L1, and Enhance STING Pathway-Mediated Antitumor Immunity
2026-09-22






